Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Britain’s pharmacists have called for tougher regulation of weight-loss drugs after reports showed some online sellers have ...

The National Pharmacy Association (NPA) has written to regulators calling for tougher rules over access to medications like ...

The National Pharmacy Association is calling for tougher rules in the market, saying people with a history of eating ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Weight-loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. The NPA has previously urged patients to ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common ...

Pharmacists say they are aware of people being wrongly prescribed the drugs who have previously had eating disorders, or ...